Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
20,250,000
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
2,038,463
-
Shares change
-
-39,412
-
Total reported value, excl. options
-
$12,985,879
-
Value change
-
-$273,838
-
Put/Call ratio
-
3.4%
-
Number of buys
-
6
-
Number of sells
-
-8
-
Price
-
$6.37
Significant Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) as of Q1 2022
26 filings reported holding NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value per share as of Q1 2022.
enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,038,463 shares
of 20,250,000 outstanding shares and own 10% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (781,615 shares), ACT CAPITAL MANAGEMENT, LLC (401,200 shares), VANGUARD GROUP INC (278,787 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (219,180 shares), GEODE CAPITAL MANAGEMENT, LLC (80,045 shares), Kepos Capital LP (50,000 shares), TWO SIGMA ADVISERS, LP (49,600 shares), BlackRock Inc. (38,441 shares), MORGAN STANLEY (35,954 shares), and TWO SIGMA INVESTMENTS, LP (33,372 shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.